Literature DB >> 22182771

Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.

Erez Koren1, Anjali Apte, Ankur Jani, Vladimir P Torchilin.   

Abstract

pH-sensitive PEGylated (with PEG-PE) long-circulating liposomes (HSPC:cholesterol and Doxil®), modified with cell-penetrating TAT peptide (TATp) moieties and cancer-specific mAb 2C5 were prepared. A degradable pH-sensitive hydrazone bond between a long shielding PEG chains and PE (PEG(2k)-Hz-PE) was introduced. TATp was conjugated with a short PEG(1k)-PE spacer and mAb 2C5 was attached to a long PEG chain (2C5-PEG(3.4k)-PE). The "shielding" effect of TATp by long PEG chains was investigated using three liposomal models. At normal pH, surface TATp moieties are "hidden" by the long PEG chains. Upon the exposure to lowered pH, this multifunctional carrier exposes TATp moieties after the degradation of the hydrazone bond and removal of the long PEG chains. Enhanced cellular uptake of the TATp-containing immunoliposomes was observed in vitro after pre-treatment at lowered pH (using flow cytometry and fluorescence microscopy techniques). The presence of mAb 2C5 on the liposome surface further enhanced the interaction between the carrier and tumor cells but not normal cells. Furthermore, multifunctional immuno-Doxil® preparation showed increased cellular cytotoxicity of B16-F10, HeLa and MCF-7 cells when pre-incubated at lower pH, indicating TATp exposure and activity. In conclusion, a multifunctional immunoliposomal nanocarrier containing a pH-sensitive PEG-PE component, TATp, and the cancer cell-specific mAb 2C5 promotes enhanced cytotoxicity and carrier internalization by cancer cells and demonstrates the potential for intracellular drug delivery after exposure to lowered pH environment, typical of solid tumors.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22182771      PMCID: PMC3361627          DOI: 10.1016/j.jconrel.2011.12.002

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  39 in total

Review 1.  Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.

Authors:  Katrin Knop; Richard Hoogenboom; Dagmar Fischer; Ulrich S Schubert
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-23       Impact factor: 15.336

2.  Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.

Authors:  Amit A Kale; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2007 Aug-Sep       Impact factor: 5.121

3.  Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer.

Authors:  Olga Garbuzenko; Yechezkel Barenholz; Aba Priev
Journal:  Chem Phys Lipids       Date:  2005-03-02       Impact factor: 3.329

4.  Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides.

Authors:  K Remaut; B Lucas; K Braeckmans; J Demeester; S C De Smedt
Journal:  J Control Release       Date:  2006-11-07       Impact factor: 9.776

5.  Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

6.  Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates.

Authors:  Amit A Kale; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2007-02-20       Impact factor: 4.774

7.  Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Eur J Pharm Sci       Date:  2007-06-07       Impact factor: 4.384

8.  Environment-responsive multifunctional liposomes.

Authors:  Amit A Kale; Vladimir P Torchilin
Journal:  Methods Mol Biol       Date:  2010

Review 9.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

10.  Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors.

Authors:  Mohamed Nabil Khalid; Pierre Simard; Didier Hoarau; Alice Dragomir; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2006-03-24       Impact factor: 4.200

View more
  78 in total

Review 1.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  Effect of surface properties on liposomal siRNA delivery.

Authors:  Yuqiong Xia; Jie Tian; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

3.  Acylsulfonamide-Functionalized Zwitterionic Gold Nanoparticles for Enhanced Cellular Uptake at Tumor pH.

Authors:  Tsukasa Mizuhara; Krishnendu Saha; Daniel F Moyano; Chang Soo Kim; Bo Yan; Young-Kwan Kim; Vincent M Rotello
Journal:  Angew Chem Int Ed Engl       Date:  2015-04-14       Impact factor: 15.336

4.  Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms.

Authors:  Abhay U Andar; Renee R Hood; Wyatt N Vreeland; Don L Devoe; Peter W Swaan
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

Review 5.  Stimuli-responsive nanocarriers for drug delivery.

Authors:  Simona Mura; Julien Nicolas; Patrick Couvreur
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

6.  Synthesis and activity of tumor-homing peptide iRGD and histone deacetylase inhibitor valproic acid conjugate.

Authors:  Zheng-Hong Peng; Jindřich Kopeček
Journal:  Bioorg Med Chem Lett       Date:  2014-03-12       Impact factor: 2.823

7.  Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.

Authors:  Yaqin Zhu; Liang Cheng; Lifang Cheng; Fazhen Huang; Qing Hu; Ling Li; Chenmin Tian; Lin Wei; Dawei Chen
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

8.  Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.

Authors:  Parham Sahandi Zangabad; Soroush Mirkiani; Shayan Shahsavari; Behrad Masoudi; Maryam Masroor; Hamid Hamed; Zahra Jafari; Yasamin Davatgaran Taghipour; Hura Hashemi; Mahdi Karimi; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2017-12-12       Impact factor: 7.848

Review 9.  Stimuli-responsive liposomes for drug delivery.

Authors:  Y Lee; D H Thompson
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-15

Review 10.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Authors:  Claudia Corbo; Roberto Molinaro; Alessandro Parodi; Naama E Toledano Furman; Francesco Salvatore; Ennio Tasciotti
Journal:  Nanomedicine (Lond)       Date:  2015-12-11       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.